Anika Therapeutics, Inc. (ANIK)
About Anika Therapeutics, Inc.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $112.8M
- Net income
- -$10.9M
- Total assets
- $190.3M
- Market cap
- $198.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $198.9M
- Shares outstanding
- 9.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 3, 1993
Anika Therapeutics, Inc. (ANIK) Stock Price
- Reported a net loss of $10.9M in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Anika Therapeutics, Inc..
Write a review
News about Anika Therapeutics, Inc.
News & sentiment via Polygon.io
Anika Therapeutics, Inc.: frequently asked questions
Is Anika Therapeutics, Inc. an American company?
Anika Therapeutics, Inc. is a US-based company headquartered in Bedford, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Anika Therapeutics, Inc. headquartered?
Anika Therapeutics, Inc. is headquartered in Bedford, Massachusetts, United States.
Is Anika Therapeutics, Inc. publicly traded?
Yes — Anika Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ANIK on the NASDAQ.
What does Anika Therapeutics, Inc. do?
Anika Therapeutics, Inc. is an American Medical Devices company in the Health & Beauty sector.
